Skip to main content

SURI

Simplify Propel Opportunities ETF

as of 10/14/2024

NAV

$ 23.76

NAV Change

+ $ 0.27 /1.15%

Price

$ 23.81

Price Change

+ $ 0.33 /1.41%
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation.

The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.

Fund Overview

As of 10/14/2024

Ticker Symbol
SURI
Gross Expense Ratio
2.76%
Net Expense Ratio
2.51%
CUSIP
82889N624
Total Assets
$104,782,283.72
Shares Outstanding
4,410,001
Distribution Rate as of 09/30/2024 Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
Distribution Rate Close
Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
11.52%
Distribution Frequency
Quarterly
30-Day SEC Yield (Subsidized) as of 09/30/2024 SEC 30-day Yield is available once fund has a full quarter of performance.
SEC 30-Day Yield Close
SEC 30-day Yield is available once fund has a full quarter of performance.
1.49%
30-Day SEC Yield (Unsubsidized) as of 09/30/2024
1.25%
Options Available
No
Inception Date
02/07/2023
Premium/Discount (%) as of 10/14/2024
0.21%
NAV Per Share as of 10/14/2024
$23.76
Market Price as of 10/14/2024
$23.81
30-Day Median Bid-Ask Spread
1.07%
Bid/Ask
$23.60/$24.34
Midpoint Price
$23.97
Volume
3,249
NAV Symbol
SURI.NV
IOPV Symbol
SURI.IV
Shares Out. Symbol
SURI.SO
Schedule K-1
No

Management Fees

This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.

Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Management Fees1 2.75%
Distribution and Service (12b-1) Fees 0.00%
Other Expenses2 0.00%
Acquired Fund Fees and Expenses3 0.01%
Total Annual Fund Operating Expenses 2.76%
Fee Waiver4 (0.25)%
Total Annual Fund Operating Expenses After Fee Waiver 2.51%
1. Estimated for the Fund’s initial fiscal year. The Fund has agreed to pay the adviser as compensation under a management agreement a monthly advisory fee (as a percentage of daily net assets) computed at the annual rate of 2.75% on assets up to $1 billion; 2.50% on assets over $1 billion and less than $5 billion; 2.00% on assets over $5 billion and less than $10 billion; and 1.00% on assets over $10 billion.

2. Other Expenses are estimated for the Fund’s initial fiscal year.

3. Acquired Fund Fees and Expenses, are estimated for the Fund’s initial fiscal year, are the indirect costs of investing in other investment companies. The operating expenses in this fee table will not correlate to the expense ratio in the Fund’s financial highlights located in the prospectus because the financial statements include only the direct operating expenses incurred by the Fund.

4. The adviser and sub-adviser have collectively agreed to waive 0.25% of the management and sub-advisory fee on an annualized basis through December 31, 2024.

Fund Performance

As of 09/30/2024 09/30/2024

Cumulative 1 Month 3 Month 6 Month YTD 1 Year Since Inception
NAV -0.51% 9.81% 1.14% 27.92% 35.79% 22.37%
Market Price 0.95% 11.47% 2.13% 29.48% 37.48% 25.59%
Annualized 1 Year 3 Year Since Inception
NAV 35.79% 13.07%
Market Price 37.48% 14.89%
Cumulative 1 Year Since Inception
NAV 35.79% 22.37%
Market Price 37.48% 25.59%
Annualized 1 Year 3 Year 5 Year Since Inception
NAV 35.79% 13.07%
Market Price 37.48% 14.89%

Historical Premium/Discount

Calendar Year 2023 3rd Quarter of 2024
Days Traded at Premium
97
25
Days Traded at Discount
128
39

Portfolio Holdings

Ticker Name Quantity Weight
TELSAT TELESAT CDA / TE 5.625 06DEC26 144A 2,700,000 1.27%
TELSAT TELESAT CDA / TELE 6.5 15OCT27 144A 6,124,000 2.18%
- CONTRA CHINOOK THERAPE + NPV 25,000 0.01%
ABEO ABEONA THERAPEUTICS INC USD 0.01 408,584 2.44%
ACHV ACHIEVE LIFE SCIENCES INC USD 0.001 217,845 1.04%
AKRO AKERO THERAPEUTICS INC USD 0.0001 228,454 6.54%
APLT APPLIED THERAPEUTICS INC USD 0.0001 2,817,505 23.90%
ARDX ARDELYX INC USD 0.000001 689,364 3.94%
ATHA ATHIRA PHARMA INC USD 0.0001 1,492,792 0.63%
CMPS COMPASS PATHWAYS PLC USD 0.008 ADR 120,000 0.70%
EIGRQ EIGER BIOPHARMACEUTICALS USD 0.0001 90,000 0.73%
KURA KURA ONCOLOGY INC USD 0.0001 80,000 1.38%
KYMR KYMERA THERAPEUTICS INC USD 0.0001 30,515 1.34%
MAAT MAAT PHARMA SACA EUR 0.1 2,397 0.02%
MDGL MADRIGAL PHARMACEUTICALS USD 0.0001 23,294 4.79%
PAGP PLAINS GP HLDGS L P 1,272,360 22.80%
PHAT PHATHOM PHARMACEUTICALS USD 0.0001 521,935 7.61%
RNA AVIDITY BIOSCIENCES INC USD 0.0001 125,000 5.57%
SNDX SYNDAX PHARMACEUTICALS I USD 0.0001 80,000 1.51%
TCRX TSCAN THERAPEUTICS INC USD 0.0001 1,046,916 5.55%
TSAT TELESAT CORP NPV 365,781 4.79%
VRCA VERRICA PHARMACEUTICALS USD 0.0001 200,000 0.27%
ZVRA ZEVRA THERAPEUTICS INC USD 0.0001 120,000 0.93%
- EURO
- Estimated Cash 53,864 0.05%

Recent Distributions

Ex-Dividend Date Record Date Payable Date Total Distribution
N/A
$0.68000
$1.25000
$0.68000
$0.68000
Recent Distribution Disclosure
View Distribution History Supplemental Tax Information: S19(a) Notices

Register for Simplify's Investor Hub

  • In-depth case studies provide valuable insights into practical portfolio problems and their solutions
  • Simplify curated model portfolios that show investors how to incorporate alternatives into their portfolio
  • Stay up-to-date with our latest thoughts on markets via our weekly market commentaries
Create Your Account
Register Info
Contact Us